NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Evinature

Evinature

Private
IsraelHealthcare & Life Scienceshttps://evinature.com/

Last Round

Seed

Apr 15, 2025

Total Funding Raised

$4.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Evinature is a health tech company that develops and sells evidence-based herbal nutraceuticals and provides tailored gut-health protocols for patients with gastrointestinal conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

gut healthinflammatory bowel diseaseIBDcurcumin supplementnutraceuticalsprecision medicinedigestive healthulcerative colitisCrohn's diseasepersonalized nutritionDTC healthfunctional medicineevidence-based supplementsclinical nutritionbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evinature Comparables

Compare Evinature with similar companies based on industry and business-model similarity.

Evinature comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMMD, LLC
70%
Pendulum Therapeutics
67%
Healthpath Ltd
62%

Evinature Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 15, 2025
SeedJan 1, 2025
SeedDec 15, 2022

Key People

Founding team and executive leadership

Apan Amos Damri

Co-Founder CEO

Founding Team

Evinature Investors

Notable investors and investment history

Evinature investors
InvestorRounds
PeakBridgeSeed
Ratio TechnologiesSeed
Ratio TechnologiesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    Product featured on main stage at ECCO 2026 conference.

Evinature Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evinature Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evinature's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range18
Year Founded2021
Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.